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Background: The Dyspnea Management Questionnaire (DMQ) is a measure of the psychosocial
and behavioral responses to dyspnea for adults with COPD. The research objectives were to
evaluate the reliability and validity of an expanded DMQ item pool, as a preliminary step for
developing a computer adaptive test.
Methods: The original 66 items of the DMQ were used for the analyses. The sample included 63
women and 44 men with COPD (n Z 107) recruited from two urban medical centers. We used
confirmatory factor analysis to test the factor structure of the DMQ and its underlying cogni-
tive-behavioral theoretical base. The internal consistency and testeretest reliability, and
breadth of coverage of the expanded DMQ item bank were also evaluated.
Results: Five distinct dyspnea domains were confirmed using 56 original items of the DMQ: dys-
pnea intensity, dyspnea anxiety, activity avoidance, activity self-efficacy, and strategy satis-
faction. Overall, the breadth of items was excellent with a good match between sample
scores and item difficulty. The DMQ-56 showed good internal consistency reliability
(a Z 0.85eto 0.96) and good preliminary testeretest reliability over a 3-week interval
(ICC Z 0.69e0.92).
Conclusions: The DMQ demonstrated acceptable levels of reliability and validity for measuring
multidimensional dyspnea outcomes after medical, psychological, and behavioral interven-
tions for adults with COPD.
ª 2010 Elsevier Ltd. All rights reserved.ability Research Institute, Boston University School of Public Health, 715 Albany StreeteT5W, Boston,
.
(A. Norweg).
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Dyspnea is the perception and experience of labored,
uncomfortable breathing, and may produce secondary
physiological, emotional, cognitive, and behavioral
responses.1 It is the primary symptom of COPD.1e6 Such
responses to dyspnea significantly impact the functional
status and health-related quality of life of adults with
COPD.7e11 For example, adults with COPD experience loss
of social life and social withdrawal and isolation, decreased
participation in leisure activities, and decreased physical
functioning related to their dyspnea.8,12 Because dyspnea is
multifaceted and significantly impacts the functional status
and health-related quality of life of adults with pulmonary
disease, a biopsychosocial approach to dyspnea assessment
and treatment is essential.1,10,13e15
Several therapeutic interventions are available that
focus on decreasing the disabling psychological and
behavioral responses to dyspnea. These interventionsTable 1 Demographic Background of Adults with COPD
(N Z 107).
Variable
Mean Age (y) [SD] 75.1 [8.6]
Missing (%) 6.5
Female (%) 58.9
Time Since Diagnosis
Made (y) [SD]
4.4 [3.8]
Race (%) Caucasian 73.8
African
American
12.1
Asian 2.8
Hispanic 1.9
Other 0.9
Missing 8.4
Marital Status (%) Married 42.1
Other 53.3
Missing 4.6
Oxygen Use at Home (%) Yes 38.3
Missing 4.7
Table 2 Overall Fit Indices for the Five-Factor Model (N Z 107
No Model No.
Items
Chi-square (DF) Ratio P
1 5-Factor 66 133.37 (41) 3.25 0.
2 5-Factor 64 112.75 (47) 2.40 0.
3 5-Factor 62 96.78 (46) 2.10 0.
4 5-factor 56 78.15 (45) 1.74 0.
5 5-factor 56 57.67 (36) 1.60 0.
Notes: CFI Z comparative fit index, TLI Z TuckereLewis index, RMS
a based on modification indices.include: relaxation and breathing retraining, desensitiza-
tion, monitored activity training, cognitive-behavioral
treatment, and education in self-management strategies.1
The individual and long term impact and benefits of these
interventions in improving dyspnea in adults with COPD are
however largely unknown and have not been well
established.1
Limitations of existing COPD-Specific dyspnea
instruments
Existing dyspnea scales are very limited in their scope and
comprehensiveness. Most measure either dyspnea intensity
with physical activities or dyspnea self-efficacy
perceptions.16e20 Current COPD instruments do not
comprehensively capture the psychological, social and
behavioral impact of dyspnea. For example, the University
of Cincinnati Dyspnea Questionnaire (UCDQ)17 uses a one-
factor model to measure dyspnea severity with physical and
speech activities. The Pulmonary Functional Status and
Dyspnea Questionnaire Modified (PFSDQ-M)16 measures
dyspnea intensity with activities and activity levels associ-
ated with dyspnea but no other dimensions of dyspnea,
using a limited range of activities. Therefore, the full
impact of dyspnea on social and community participation
and psychological functioning is not captured by the PFSDQ-
M. Also, the COPD Self-Efficacy Scale (CSES),19 which was
developed to measure individuals’ level of confidence in
managing dyspnea in different situations, was found to
result in high rates of missing data associated with concerns
about its content validity.21
The University of California, San Diego Shortness of
Breath Questionnaire (UCSD SOBQ),17 a unidimensional
scale, measures dyspnea severity with activities of daily
living (21 items); emotional distress of dyspnea (1 item);
dyspnea cognition (1 item); and participation limitation due
to dyspnea (1 item). Single items of the SOBQ are inade-
quate from a psychometric perspective to adequately
measure the dyspnea dimensions, emotional anxiety,
cognition, and participation limitation.
The Breathing Problems Questionnaire (BPQ) for patients
with chronic bronchitis consists of 2 subscales: functional).
CFI TLI RMSEA Removed Itemsa
0000 0.820 0.873 0.146 e
0000 0.895 0.935 0.115 IIA2,IIA6
0000 0.922 0.952 0.103 IIA2,IIA6,V9,V11
0016 0.953 0.973 0.084 IIA2,IIA6,V9,V11,
V6,V8,V7,IV2,
V4, 3A3
0124 0.969 0.978 0.076 Same as model 4,
but fixed the
correlation in F1
and F5, F5 and
F3 at 0
EA Z root mean square error of approximation.
Table 3 Factor loadings and standard errors for five-factor model (N Z 107).
Items Estimation* SE
F1: Dyspnea Intensity
DI1. Getting dressed 0.850 0.036
DI2. Showering or bathing 0.862 0.036
DI3. Reaching above your head 0.842 0.041
DI4. Bending down 0.786 0.046
DI5. Walking indoors for 40 feet 0.891 0.031
DI6. Walking outdoors for 2 blocks 0.835 0.043
DI7. Walking uphill for 1 block 0.758 0.044
DI8. Carrying a 5e7 pound shopping bag 40 feet 0.814 0.042
DI9. Climbing one flight of stairs 0.824 0.038
DI10. Talking with other people for half an hour while seated 0.661 0.064
DI11. Engaging in active leisure pursuits 0.810 0.046
DI12. Participating in social activities in your community 0.884 0.039
F2: Dyspnea Anxiety
DA1A. Nervous during breathing difficulty 0.763 0.048
DA2A. Worried in general about your shortness of breath 0.800 0.042
DA3A. Afraid when it was hard for you to breathe 0.766 0.046
DA4A. Panicked when you couldn’t breathe well 0.776 0.048
DA5A. Upset when you had to stop and rest due to shortness of breath 0.745 0.047
DA6A. Tense if you thought about prior episodes of shortness of breath 0.774 0.05
DA7A. You had little control over your shortness of breath 0.679 0.059
DAB1. Intense breathing discomfort 0.776 0.049
DAB2. Your shortness of breath being life-threatening 0.822 0.047
DAB3. Panicking during a future breathing attack 0.913 0.035
DAB4. Chest tightness 0.792 0.054
DAB5. Delay in your breathing returning to normal after activity 0.707 0.057
DAB6. Increased breathing effort with exercise 0.625 0.063
DAB7. Not surviving an episode of shortness of breath 0.828 0.048
DAB8. Loss of breathing control during routine daily activities 0.825 0.044
DAB9. Something terrible happening to you when short of breath 0.826 0.045
F3: Activity Avoidance
AA1A. Hold back from doing activities that you enjoy 0.883 0.031
AA2A. Stay at home more often than you wanted to 0.887 0.031
AA3A. Stay sitting for long periods of time 0.748 0.046
AA4A. Keep to yourself or avoid seeing other people 0.681 0.057
AA5A. Be less active than you would have liked to be 0.814 0.04
AAB1. Bending down 0.779 0.049
AAB2. Walking 0.863 0.035
AAB3. Physically exercising 0.840 0.036
AAB4. Climbing stairs 0.797 0.045
AAB5. Doing housework 0.863 0.036
AAB6. Shopping 0.864 0.036
AAB7. Participating in family activities 0.880 0.035
AAB8. Pursuing active leisure interests 0.847 0.039
AAB9. Social activities in your community 0.856 0.038
AAB10. Engaging in sexual activities 0.655 0.064
F4: Activity Self-Efficacy 0.914 0.082
SE1. Do light physical activity 0.870 0.102
SE2. Walk outdoors 0.437 0.109
SE3. Experience extreme cold or hot weather conditions 0.749 0.074
SE4. Experience stressful situations 0.629 0.098
SE5. Smell strong odors 0.754 0.079
SE6. Travel far from home 0.914 0.082
F5: Strategy Satisfaction
SS1. Use controlled breathing when feeling stressed 0.942 0.047
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Table 3 (continued )
Items Estimation* SE
SS2. Use controlled breathing with daily activities 0.842 0.045
SS3. Use controlled breathing with exercise 0.732 0.061
SS4. Use relaxation techniques 0.854 0.048
SS5. Take medications correctly as prescribed 0.642 0.073
SS6. Keep good eating habits 0.437 0.106
SS7. Assert your needs 0.555 0.082
*All factor loadings: p < 0.05.
Outcome measurement for COPD 445problems and negative evaluations.22 However, all 6 items
of the negative evaluations subscale cross-load with the
problems subscale indicating that the BPQ-33 most likely
consists of only one factor. The items related to negative
evaluations are not specific to anxiety but also relate to
other emotions. The content range of the BPQ short-form is
also limited.23 The BPQ requires further psychometric
testing, especially of its construct validity in addition to its
internal consistency and testeretest reliability.
The three subscales of the St. George’s Respiratory
Questionnaire (SGRQ)24 (symptoms, activity, and impacts)
do not separate out dyspnea, but instead measure several
COPD symptoms combined. Similarly, only the coping skills
subscale of the Seattle Obstructive Lung Disease Ques-
tionnaire25 (SOLQ) specifically measures dyspnea; it
combines a question about dyspnea self-efficacy with three
questions about dyspnea anxiety. The other 3 subscales of
the SOLQ (physical function, emotional function, and
satisfaction with care) measure the impact of lung prob-
lems in general.
The Chronic Respiratory Disease Questionnaire
(CRQ)20,26 consisting of 20 items measures emotional,
physical, and behavioral responses to several COPD symp-
toms and not dyspnea specifically, reducing its sensitivity to
measuring change in dyspnea. It has two versions, an
interview-administered version and a self-reported version.
The individualized, non-standardized activities of the CRQ
dyspnea subscale (of both versions) render it inappropriate
for comparisons between groups of patients with COPD and,
therefore, randomized clinical trials.27 The CRQ dyspnea
subscale has also been shown to have low internal consis-
tency reliability.28 The interview-administered version of
the CRQ has high respondent burden, as it can take 30 min
to initially administer via interview. While the self-reported
version takes less time, approximately 10 min, to initially
complete, the individualized activities of the dyspneaTable 4 Factor correlations.
F1
F1: Dyspnea Intensity e
F2: Dyspnea Anxiety 0.688**
F3: Activity Avoidance 0.802**
F4: Activity
Self-Efficacy
0.180**
F5: Strategy
Satisfaction
0a
**p < 0.05.
a Fixed Parameter.subscale need to be transcribed for repeat administrations,
which increases its administration burden.
Dyspnea measures such as the baseline dyspnea index
(BDI),29 transition dyspnea index (TDI),29 and the British
Medical Research Council (MRC)29 are categorical scales
that are further limited in their scope and precision of
measurement.30 The MRC measures magnitude of tasks that
provoke dyspnea while the BDI and TDI measure functional
impairment, magnitude of effort, and magnitude of task
associated with dyspnea. The MRC was not designed to
measure dyspnea change over time.
In summary, we developed themultidimensional Dyspnea
Management Questionnaire (DMQ) to overcome the defi-
ciencies of existing instruments used in clinical and research
settings for measuring treatment outcomes for patients with
COPD.31 The DMQ addresses a need for a comprehensive
dyspnea measure, that captures the physical, emotional
(anxiety), behavioral, and cognitive aspects of dyspnea, in
order to enhance our understanding of patients’ dyspnea
experience and the effectiveness of treatments.
Previous research supported the reliability and validity
of the DMQ in a sample of 85 participants (73 with physi-
cian-confirmed COPD and 12 with physician-confirmed
asthma).29 The DMQ items were developed using qualitative
interview data with patients with COPD, a comprehensive
literature review, and individual semi-structured interviews
with a sample of 4 adults with COPD who had participated
in a pulmonary rehabilitation program and 8 interdisci-
plinary clinicians specializing in pulmonary medicine and
rehabilitation to test the relevance and content validity of
the items and subscales. Sixty-six items were rated by
the12 experts to be relevant and to have content validity.
The DMQ was reduced to 30 items, which were found to
have high internal consistency (a Z 0.87e0.96) and
testeretest reliability over 2.5 weeks (ICC Z 0.71e0.95).
The results provided strong evidence for the concurrentF2 F3 F4
e
0.788** e
0.232** 0.252** e
0.247** 0a 0.497**
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Figure 1 Item Person Map (Dyspnea Intensity).
446 A. Norweg et al.validity of the dyspnea intensity, dyspnea anxiety, and
activity avoidance subscales of the DMQ-30, while more
testing was indicated for the activity self-efficacy and
strategy satisfaction scales. The DMQ discriminated
between COPD adults with different severities of lung
disease. The DMQ’s factor structure and range of difficulty
levels were not examined in previous work. Also, the
previous research aimed to limit the number of DMQ items
since the DMQ was initially designed to be administered
using a fixed-format. In contrast, the current research was
undertaken to begin to evaluate the psychometric proper-
ties of an expanded pool of items for the DMQ in prepara-
tion for constructing a computer adaptive test (CAT)
version of the instrument, including its factor structure,
internal consistency reliability, testeretest reliability, and
breadth using Item Response Theory (IRT) measurement
techniques.32
Methods
Samples
Data on 107 subjects with pulmonary disease were derived
from two sources: 73 adults with physician-confirmed
pulmonary disease from our initial work31 supplemented by
an additional 34 adults with physician-confirmed COPD
referred for pulmonary rehabilitation at the Rusk Institute
of Rehabilitation Medicine.The Dyspnea Management Questionnaire
The DMQ consists of five conceptually-derived dyspnea
dimensions: dyspnea intensity, dyspnea anxiety, activity
avoidance, activity self-efficacy, and satisfaction with
strategy use. Cognitive-behavioral theory underlies the DMQ
including: the model of dyspnea,7 the cognitive-behavioral
model of panic,33 cognitive-perceptual model of somatic
interpretation,34 fear-avoidance model,35 social learning
theory of self-efficacy,36 in addition to the theory of patient
satisfaction.37 The activity self-efficacy scale of the DMQ is
based on the COPD self-efficacy scale.19 The DMQ uses
a 7-point Likert response scale that ranges from 0 to 6 with
higher scores representing better dyspnea-related function.
For example, the activity avoidance scale of the DMQ ranges
from (6) “never” to (0) “all the time”. To calculate each
subscale score, raw values for items are summed and then
divided by the number of items in the subscale to obtain
a mean score. The DMQ was developed to be both a clinical
and a research outcome scale to measure the effectiveness
of multi-disciplinary treatments that aim to reduce the
emotionally distressing and disabling responses to dyspnea
and promote adaptive coping for adults with COPD.
Testing procedures
Institutional review board approvals were obtained prior to
commencing DMQ psychometric testing. Building on our
Figure 2 Item Person Map (Dyspnea Anxiety).
Outcome measurement for COPD 447previous sample,31 we recruited an additional sample of 34
adults using mail survey procedures.38 Patients with a diag-
nosis of COPD and referred for pulmonary rehabilitation
services at the pulmonary outpatient clinic in 2005 and 2006
were mailed a recruitment letter. People who consented via
postcard were mailed the DMQ-66 and an informed consent
form to complete and return. Respondents completed the
DMQ-66 twicewithin a threeweek interval, in addition to two
questions about their health stability.
Analysis
We first used a series of confirmatory factor analyses to
analyze how well the data fit the theoretically derived factor
structure hypothesized for the DMQ.39 This factor analysis
method, based on the polychoric correlationmatrix, was used
because our datawerenot normally distributed. Since there is
no universally accepted fit index, we usedmultiple goodness-
of-fit indices including chi-square to degrees of freedom
ratio,40 Comparative Fit index (CFI),41 TuckereLewis Index
(TLI)41 and Root Mean Square Error of Approximation (RMSEA)
to check the model fit.42 For the chi-square to degrees of
freedom ratio, an index of less than 3 is generally accept-
able.42 CFI and TLI compare the model to a baseline null
model; possible values range from 0 to 1; 0.95 or higher
suggests an acceptable fit.41 RMSEA assessesmisfit per degreeof freedom; values less than 0.08 suggest an acceptable fit,
and values less than 0.05 suggest a very good fit.42
The remaining 56 items were used for all subsequent
analyses. Rasch item response theory (IRT) analyses were
used to estimate item difficulty parameters and compare
them to person ability estimates for each subscale.43,44
Greater breadth of measurement and precision are ach-
ieved when item locations of a construct are spread across
a respective continuum.45,46
To check the scale’s internal consistency, we calculated
Cronbach’s alphas for each of the subscales. Testeretest
reliability of the DMQ was assessed using intraclass corre-
lation coefficients. For inclusion in testeretest reliability
analyses, respondents needed to deny both hospitalization
and a noticeable change in their health in the last month.Results
Sample characteristics
The sample consisted of 107 adults with COPD from two
medical centers in New York City. A majority of adults were
female (58.9%), married (42.1%), and Caucasian (73.8%); see
Table 1. The mean age of participants was 75.1 years
(SDZ 8.6); 38.3% required supplemental oxygenuse at home.
-5
-4.5
-4
-3.5
-3
-2.5
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5 Subjects or 
Categories
Person
0 5 10 15 20- 2 0 - 15 - 10 - 5 0
Item Categories
Figure 3 Item Person Map (Activity Avoidance).
448 A. Norweg et al.Construct validity: dyspnea domains
Confirmatory factor analysis supported the five-factor
conceptually-derived model for the DMQ: Dyspnea Inten-
sity, Dyspnea Anxiety, Activity Avoidance, Activity Self-
efficacy, and Strategy Satisfaction (see Tables 2 and 3). The
first factor, dyspnea intensity, consisting of 12 items, is the
amount of dyspnea experienced with performing self-care,
mobility, home management, community, leisure, and
social activities. Dyspnea anxiety, consisting of 16 items, is
the magnitude of anxiety symptoms associated with short-
ness of breath. Activity avoidance, comprised of 15 items,
is the extent to which anxiety symptoms, related to dysp-
nea, contribute to avoidance of daily activities. Activity
self-efficacy, with 6 items, is an individual’s perceived
confidence in being able to manage shortness of breath
with activity participation. Strategy satisfaction,
comprised of 7 items, is the individual’s evaluation of his or
her mastery of dyspnea management strategies.
Analyses of modification indices resulted in 10 of the 66
items being removed from the model. Two items, confident
that you could relieve your shortness of breath, calm even if
your breathing took effort, were deleted due to poor item fit.
In a 5-factor CFA, removing these two items from the 2nd
factor improved the model fit (CFI Z 0.895, TLI Z 0.935,
RMSEA Z 0.115). Eight additional items were removed from
the3rd,4th,and5th factors basedonthemodification indices,
further improving themodel fit (Chi-square (DF)Z 78.15 (45),
CFIZ 0.953, TLIZ 0.973, RMSEAZ 0.084). These items wererespectively: avoid smoking, exercise regularly, lean forward
to recover fromexercise or activity, protect lungs, use devices
that help you save energy, do moderate physical activity, use
efficient movements, and keep strong emotions inside.
Correlations between 3rd factor and 5th factor, 1st factor and
5th factor were not significant. Therefore, we fixed these
three correlations at 0, which further improved the model fit
(Chi-square (DF) Z 57.67(35), CFI Z 0.969, TLI Z 0.978,
RMSEAZ 0.076). Three of the DMQ factors, Dyspnea Intensity,
Dyspnea Anxiety, and Activity Avoidance, weremoderately to
highly correlated (rZ 0.69 to 0.80); see Table 4.
Item calibrations
The breadths of the five DMQ subscales are shown as item
person histograms in Figs. 1e5. They show the hierarchical
distributions of estimated item difficulty and person ability
with zero indicating the standardized mean or midpoint of
difficulty of each subscale. Floor and ceiling effects were
minimal. Floor effects ranged from 0 to 1% (n Z 1) and
ceiling effects were 0e2% (n Z 2) for the five subscales.
Reliability
The Cronbach’s alphas for each of the DMQ subscales
ranged from 0.85 to 0.96 (see Table 5). We estimated the
testeretest reliability of the DMQ over a mean interval of 3
weeks (21.5 days, SD Z 10.97) using intraclass correlation
Figure 4 Item Person Map (Activity Self-Efficacy).
Outcome measurement for COPD 449coefficients (ICC). ICCs ranged between 0.69 and 0.92 for
the five subscales (see Table 6).
The response rate was 51% for re-administration of the
DMQ. Some respondents (n Z 12) were not asked to
complete the DMQ twice because they did not consent to
receive a follow-up survey; had fallen; died; completed the
questionnaire with assistance (n Z 1); or skipped sections
of the questionnaire the first time. A sample of 35 adults
with stable COPD was used. The sample was 65.7% female,
42.9% married, 94.3% Caucasian, and had a mean age of
75.7 years (SD Z 7.26). Testeretest participants differed
significantly on use of supplemental oxygen, requiring less
oxygen at home, compared to participants who did not
respond twice (p Z 0.02); all other demographics did not
differ significantly between the two groups.Discussion
We confirmed the five-factor structure of the DMQ with 56
items. The strengths of the DMQ are its comprehensive,
multi-factor model structure of dyspnea and wide range of
item difficulty levels. The dyspnea domains of anxiety,
activity avoidance, and strategy satisfaction are not
measured by any other dimensional dyspnea instrument for
adults with COPD. The multifactorial model of the DMQ
facilitates the study of dyspnea to determine which
dimensions specifically improve after clinical interventions.The DMQ can help to, (1) improve dyspnea measurement in
clinical and research settings for adults with COPD, (2)
increase our understanding of how to improve dyspnea
symptom management, and (3) facilitate the appropriate
selection of patients for different dyspnea interventions.
The DMQ is intended to be used as both a clinical and
research outcome tool, to compare individual and group
dyspnea scores, for adults with COPD in order to evaluate
the effectiveness of clinical interventions, including
adjunctive pulmonary rehabilitation therapies whose
benefits are largely unknown.47,48
The appropriate selection of a dyspnea assessment to
measure treatment effectiveness should be based on
a match between the dyspnea domains measured by the
assessment and the dimensions of dyspnea to be targeted by
the treatment. If treatment specifically targets psycholog-
ical and behavioral dimensions of dyspnea, then the DMQ is
a good choice to evaluate the effectiveness of the medical,
cognitive-behavioral, or rehabilitative treatment compo-
nent. For example, if therapy is designed to (1) increase
a person’s dyspnea tolerance, (2) limit the distress and
disabling effects of dyspnea, and or (3) facilitate a healthy,
active lifestyle and coping strategies, then the DMQwould be
a good outcome instrument to use.
Although there were moderate to high correlations
between three of the DMQ factors, extensive model fitting
was completed and the best model fit was achieved with
a solution that revealed five distinct and interpretable
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Figure 5 Item Person Map (Strategy Satisfaction).
450 A. Norweg et al.domains. All confirmatory factor analysis fit indices met
acceptable standards using 56 items of the DMQ.
In developing the current version of the DMQ, 10 items
were removed (from the initial pool of 66 DMQ items)
following factor analyses. Most of these items came from
factor five, strategy satisfaction. The specific coping strat-
egies of using efficient movements and forward leaning
postures, assistive devices, avoiding environmental lung
irritants and smoking, and exercising regularly were
removed. Less diversity in coping strategies is measured by
the strategy satisfaction scale as a result. The item, “do
moderate physical activity” did not fit the activity self-effi-
cacy scale. Thismay indicate that the examples given for this
item, carrying grocery bags or climbing 1 flight of stairs, need
to be measured separately for improved construct validity.
The DMQ-56 improves on the breadth of measurement
compared to the DMQ-30. For example, many more physicalTable 5 Internal Consistency Reliability of the Five-Factor Mod
Scale Cronbach’s Alpha Numb
Dyspnea Intensity 0.95 12
Dyspnea Anxiety 0.95 16
Activity Avoidance 0.96 15
Activity Self-Efficacy 0.86 6
Strategy Satisfaction 0.85 7and social activities are included in the dyspnea intensity
and activity avoidance scales, including “getting dressed”,
“reaching above your head”, “bending down”, “talking
with other people”, and “sexual activities”. The larger item
pool for the dyspnea anxiety scale includes more items
representing hypervigilance and catastrophic interpreta-
tion responses to dyspnea, including thoughts about lack of
control and death and dying. The activity self-efficacy scale
includes more items about managing dyspnea in different
environmental contexts.
IRT techniques provided support for the breadth of
measurement across different ranges of ability levels for
each factor of the DMQ. Overall, IRT analyses showed
excellent breadth of the DMQ for the five subscales and
a good match of item difficulty compared to sample
distributions. There was a very good match for the dyspnea
intensity subscale between items and abilities. For dyspneael.
er of items Mean Variance N
3.53 0.71 103
4.20 0.31 99
3.76 0.20 91
2.91 0.09 92
3.76 0.31 92
Table 6 TesteRetest Reliability of the DMQ over a 3.1
week interval (N Z 35).
Dimension ICC N p Values
Dyspnea Intensity 0.91 33 <0.001
Dyspnea Anxiety 0.88 31 <0.001
Activity Avoidance 0.92 31 <0.001
Activity Self-Efficacy 0.83 32 <0.001
Strategy Satisfaction 0.69 32 <0.001
ICC: Intraclass Correlation Coefficient.
Outcome measurement for COPD 451anxiety, while the match was good, item locations were
skewed toward the lower end of the logit scale compared to
subjects’ abilities. For the activity avoidance subscale,
item difficulty matched person ability except for a few
people functioning at the highest (most difficult) level of
the continuum. For the activity self-efficacy and strategy
satisfaction subscales, items matched sample distributions
well except at the very lowest functional proficiency of the
scales. Further testing is needed with diverse samples of
patients with COPD to confirm that the IRT item calibrations
can be generalized to the larger population of adults with
COPD.
The results also provided support for the internal consis-
tency and testeretest reliability over a 3-week interval of
the DMQ. The results of the testeretest reliability analyses
are preliminary given the response rate for retesting and
since results cannot be generalized to patients who require
higher levels of supplemental oxygen. Further testeretest
reliability testing is needed to confirm the results in a more
heterogeneous sample with respect to ethnicity and
supplemental oxygen use. A 3-week interval may also have
been too long for testeretest reliability since 17 individuals
(31.5%) reported a change in health in this time period.
The newly expanded 56 items of the DMQ also provide
the foundation for developing a computer adaptive test
(CAT)49 version of this instrument. In preparation for using
computer adaptive testing, we were interested to evaluate
the reliability and validity of a larger DMQ item pool. CAT
applications require a large set of items in any one outcome
domain, items that consistently scale along a dimension of
low to high proficiency. CAT and item response theory
(IRT)50,51 techniques are currently being applied to the
development of a new generation of function and disability
assessment instruments51,52 and we believe may be ideally
suited for dyspnea assessment.
We believe our sample for field testing the DMQ items
was a reasonably representative sample of adults with
COPD for which the DMQ was intended. Our patient sample
had a verified diagnosis of COPD and was obtained from two
medical centers. The DMQ is intended for both clinical and
research use with adults with COPD. It can be employed to
compare individual patient’s and groups of patients’ dysp-
nea scores before and after clinical interventions such as
pulmonary medicine, pulmonary rehabilitation, cognitive-
behavioral therapy, controlled breathing training, exercise
therapy, psychological support, desensitization, relaxation
therapy, and interdisciplinary self-management education
in order to ascertain their effectiveness.
A limitation of this study was the small sample size.
MacCallum et al.,53e55 however, provided evidence thata stable, valid factor solutionwith close approximation to the
major common factors can be achieved with smaller sample
sizes. They contended that the effect of sampling error is
minimal if unique loadings or variances are consistently low.
MacCallum et al.’s research refutes traditional rules of
thumb about sample size in factor analysis. Nonetheless, we
need to interpret the confirmatory factor analysis findings
with some caution given their preliminary nature.
Our study findings may have selection bias resulting from
low initial responses to mailed recruitment letters. We
were however unable to estimate whether responders
differed from non-responders because medical data on non-
responders was not available to the researchers. The
results of our study, using a sample of patients from two
New York City medical centers, may not generalize to the
larger U.S. population of adults with COPD. Therefore,
further psychometric testing of the DMQ using samples from
other parts of the U.S. would be useful.
Conclusions
The DMQ-56 improves on the conceptual clarity and
measurement breadth of the DMQ-30. The results of this
study provide preliminary empirical evidence of five distinct
dimensions of dyspnea represented by 56 items of the DMQ,
capturing a wide continuum of functional abilities and
satisfaction levels. The expanded DMQ-56 meets a need to
comprehensivelymeasure the cognitive, emotional, sensory,
and behavioral components of dyspnea for adults with COPD.
It uses dimensional scaling and IRT analyses to measure the
distinct dyspnea domains of dyspnea intensity, dyspnea
anxiety, activity avoidance, activity self-efficacy, and
strategy satisfaction. The 56-item DMQ demonstrated good
psychometric properties including internal consistency and
testeretest reliability and construct validity. The results
support using the DMQ to measure change in dyspnea func-
tioning following clinical interventions for adults with COPD.
The analyses undertaken and results from this study
were important preparatory steps for future work to build
dyspnea item banks and apply computer adaptive testing
methods for dyspnea outcome measurement in adults with
COPD. The study results provide a beginning foundation on
which to develop a CAT version of the DMQ that has the
potential to further improve the instrument’s feasibility of
administration, breadth of measurement, and sensitivity to
clinically meaningful change in dyspnea-related outcomes.
Future work planned on the DMQ will also include evalu-
ating its responsiveness to change following therapeutic
pulmonary interventions.
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